Skip to main content
Erschienen in: International Journal of Clinical Oncology 1/2011

01.02.2011 | Introduction To Review Articles

Oral premalignant lesions

verfasst von: Teruo Amagasa

Erschienen in: International Journal of Clinical Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

Oral cancer is the most common head and neck cancer, found in 270,000 patients annually worldwide [1]. The mortality rate due to cancer has continued to increase over the last 50 years in Japan. Within the last 25 years, carcinoma has become the leading cause of death in Japan, with the number of people dying from oral and pharyngeal carcinoma increasing approximately threefold [2]. While early detection and early treatment of oral cancer are important for improving the survival rate of patients, prevention of oral cancer will clearly contribute most to decreasing its death rate. …
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55:74–108CrossRef Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55:74–108CrossRef
2.
Zurück zum Zitat Health and Welfare Statistics Association (2009) Statistical abstracts on health and welfare in Japan Health and Welfare Statistics Association (2009) Statistical abstracts on health and welfare in Japan
3.
Zurück zum Zitat Amagasa T, Yamashiro M, Ishikawa H (2006) Oral leukoplakia related malignant transformation. Oral Sci Int 3:45–55 Amagasa T, Yamashiro M, Ishikawa H (2006) Oral leukoplakia related malignant transformation. Oral Sci Int 3:45–55
4.
Zurück zum Zitat Kramer IRH, Lucas RB, Pindborg JJ et al (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539 Kramer IRH, Lucas RB, Pindborg JJ et al (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539
5.
Zurück zum Zitat Pindborg JJ (1980) Oral cancer and precancer. John Wright & Sons Ltd, Bristol, pp 15–19 Pindborg JJ (1980) Oral cancer and precancer. John Wright & Sons Ltd, Bristol, pp 15–19
6.
Zurück zum Zitat Axell T, Holmstrup P, Kramer IRH et al (1984) International seminar in oral leukoplakia and associated lesions related tobacco habits. Commun Dent Epidermiol 12:145–154CrossRef Axell T, Holmstrup P, Kramer IRH et al (1984) International seminar in oral leukoplakia and associated lesions related tobacco habits. Commun Dent Epidermiol 12:145–154CrossRef
7.
Zurück zum Zitat Axell T, Pindborg JJ, Smith CJ et al (1996) Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21 1994. J Oral Pathol Med 25:49–54 Axell T, Pindborg JJ, Smith CJ et al (1996) Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21 1994. J Oral Pathol Med 25:49–54
8.
Zurück zum Zitat Pindborg JJ, Reichart PA, Smith CJ et al (1997) Histological typing of cancer and precancer of the oral mucosa, 2nd edn. Springer, Berlin Pindborg JJ, Reichart PA, Smith CJ et al (1997) Histological typing of cancer and precancer of the oral mucosa, 2nd edn. Springer, Berlin
9.
Zurück zum Zitat Warnakulasuriya S, Johnson NW, van der Wall I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575–580CrossRefPubMed Warnakulasuriya S, Johnson NW, van der Wall I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575–580CrossRefPubMed
10.
Zurück zum Zitat van der Wall I (2009) Potentially malignant disorders of the oral mucosa and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45:317–323CrossRef van der Wall I (2009) Potentially malignant disorders of the oral mucosa and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45:317–323CrossRef
11.
Zurück zum Zitat Warnakulasuriya S, Reibel J, Bouquot J et al (2008) Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37:127–133CrossRefPubMed Warnakulasuriya S, Reibel J, Bouquot J et al (2008) Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37:127–133CrossRefPubMed
12.
Zurück zum Zitat Pindborg JJ, Reibel J, Holmstrup P (1985) Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 14:698–708CrossRefPubMed Pindborg JJ, Reibel J, Holmstrup P (1985) Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 14:698–708CrossRefPubMed
13.
Zurück zum Zitat Abbey L, Kaugars GE, Gunsolley JC et al (1995) Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol 80:188–191 Abbey L, Kaugars GE, Gunsolley JC et al (1995) Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol 80:188–191
14.
Zurück zum Zitat Karabulut A, Reibel J, Therkildsen MH et al (1995) Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24:198–200CrossRefPubMed Karabulut A, Reibel J, Therkildsen MH et al (1995) Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24:198–200CrossRefPubMed
15.
Zurück zum Zitat Barnes L, Eveson JW, Reichart P et al (eds) (2005) World Health Organization classification of tumours, pathology and genetics of head and neck tumours. IARC Press, Lyon pp 140–143, 163–175, 177–179 Barnes L, Eveson JW, Reichart P et al (eds) (2005) World Health Organization classification of tumours, pathology and genetics of head and neck tumours. IARC Press, Lyon pp 140–143, 163–175, 177–179
16.
Zurück zum Zitat Gale N, Kambic V, Michaels L et al (2000) The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 7:240–251CrossRefPubMed Gale N, Kambic V, Michaels L et al (2000) The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 7:240–251CrossRefPubMed
17.
Zurück zum Zitat Hellquist H, Cardesa A, Gale N et al (1999) Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 34:226–233CrossRefPubMed Hellquist H, Cardesa A, Gale N et al (1999) Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 34:226–233CrossRefPubMed
18.
Zurück zum Zitat Hellquist H, Lundgren J, Olofsson J (1982) Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords a follow-up study. Clin Otolaryngol 7:11–27CrossRefPubMed Hellquist H, Lundgren J, Olofsson J (1982) Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords a follow-up study. Clin Otolaryngol 7:11–27CrossRefPubMed
19.
Zurück zum Zitat Kambic V, Gale N (1995) Epithelial hyperplastic lesions of the larynx. Elsevier, Amsterdam Kambic V, Gale N (1995) Epithelial hyperplastic lesions of the larynx. Elsevier, Amsterdam
20.
Zurück zum Zitat Amagasa T, Yokoo E, Sato K et al (1985) A study of the clinical characteristics and treatment of oral carcinoma in situ. Oral Surg Oral Med Oral Pathol 60:50–55CrossRefPubMed Amagasa T, Yokoo E, Sato K et al (1985) A study of the clinical characteristics and treatment of oral carcinoma in situ. Oral Surg Oral Med Oral Pathol 60:50–55CrossRefPubMed
21.
Zurück zum Zitat Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 53:563–568CrossRefPubMed Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 53:563–568CrossRefPubMed
22.
Zurück zum Zitat Sakr WA, Gale N, Gnepp DR et al (2009) Squamous intraepithelial neoplasia of the upper aerodigestive tract. In: Gnepp DR (ed) Diagnostic surgical pathology of the head and neck, 2nd edn. Saunders, Philadelphia Sakr WA, Gale N, Gnepp DR et al (2009) Squamous intraepithelial neoplasia of the upper aerodigestive tract. In: Gnepp DR (ed) Diagnostic surgical pathology of the head and neck, 2nd edn. Saunders, Philadelphia
23.
Zurück zum Zitat Shimizu M, Nagata K, Yamaguchi H et al (2009) Squamous intraepithelial neoplasia of the esophagus: past, present, and future. J Gastroenterol 44:103–112CrossRefPubMed Shimizu M, Nagata K, Yamaguchi H et al (2009) Squamous intraepithelial neoplasia of the esophagus: past, present, and future. J Gastroenterol 44:103–112CrossRefPubMed
24.
Zurück zum Zitat The Working Committee of New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa, Japanese Society for Oral Pathology (2007) Oral CIS (JSOP) Catalog: histopathological variations. Sunashobo Publishing Co Ltd, Tokyo The Working Committee of New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa, Japanese Society for Oral Pathology (2007) Oral CIS (JSOP) Catalog: histopathological variations. Sunashobo Publishing Co Ltd, Tokyo
Metadaten
Titel
Oral premalignant lesions
verfasst von
Teruo Amagasa
Publikationsdatum
01.02.2011
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 1/2011
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0158-2

Weitere Artikel der Ausgabe 1/2011

International Journal of Clinical Oncology 1/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.